Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SJIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00570661
What this trial is testing

Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis

Who this might be right for
Active SystemicOnset Juvenile Idiopathic Arthritis
Italfarmaco 17
Not applicableLooking for participantsNCT05925452
What this trial is testing

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Active Systemic Juvenile Idiopathic Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 290
Large-scale testing (Phase 3)Study completedNCT02334748
What this trial is testing

Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Who this might be right for
Systemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Active Not RecruitingNCT05814159
What this trial is testing

Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Juvenile OnsetStill's Disease, Adult-Onset
Swedish Orphan Biovitrum 15
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Early research (Phase 1)Study completedNCT01803321
What this trial is testing

Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Regeneron Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00144599
What this trial is testing

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 56
Large-scale testing (Phase 3)Ended earlyNCT00886769
What this trial is testing

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 84
Early research (Phase 1)Study completedNCT01904292
What this trial is testing

Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 52
Early research (Phase 1)Ended earlyNCT04752371
What this trial is testing

Evaluate Camoteskimab in Participants With Still's Disease

Who this might be right for
Adult Onset Still's Disease
Apollo Therapeutics Ltd 5
Testing effectiveness (Phase 2)Study completedNCT03311854
What this trial is testing

Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more
Swedish Orphan Biovitrum 14
Large-scale testing (Phase 3)Study completedNCT00277251
What this trial is testing

Alendronate Osteoporosis Study

Who this might be right for
Glucocorticoid-Associated Osteopenia and Osteoporosis
Boston Children's Hospital 20
Large-scale testing (Phase 3)Study completedNCT00889863
What this trial is testing

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis With Active Flare
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT00891046
What this trial is testing

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 270
Large-scale testing (Phase 3)Study completedNCT02396212
What this trial is testing

Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Looking for participantsNCT02991469
What this trial is testing

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 51
Large-scale testing (Phase 3)Study completedNCT00339157
What this trial is testing

Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Who this might be right for
Systemic-Onset Juvenile Idiopathic Arthritis
Institut National de la Santé Et de la Recherche Médicale, France 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04088396
What this trial is testing

Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Eli Lilly and Company 58
Large-scale testing (Phase 3)Study completedNCT02296424
What this trial is testing

SS-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (SJIA)
Novartis Pharmaceuticals 182
Next Page